News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
The search for a cure
Three Types of HIV Cure: What do they mean, and where do we go from here?

If you’ve been following the news lately, you may be starting to wonder why anybody ever thought curing HIV was so challenging. On March 3 we heard the news that a child appeared to have been cured. Hard on the heels of that report came the news that 14 individuals in France had been functionally cured. So what do these cases mean? How are they similar, and how do they differ? And importantly for HIV research, where do we go from here?

Published
17 April 2013
From
amfAR
Outcomes and prognosis
Life expectancy for South African patients who start HIV therapy with CD4 cell counts above 200 is 'near normal'

HIV-positive patients in South Africa can have a near-normal life expectancy, provided that they start antiretroviral therapy promptly, investigators report in the open access journal PLoS Medicine.

Published
15 April 2013
By
Michael Carter
Treatment for women
Option B+: Understanding perspectives and experiences of women living with HIV

Option B+ is a prevention of vertical transmission approach for expectant mothers living with HIV in which women are immediately offered treatment for life regardless of their CD4 count. This approach offers advantages such as protection of partner(s) and (unborn) child, as well as benefits to the woman's health, but also carries with it risks. In the attached publication, GNP+ and ICW report on the results of 8 different focus group discussions that discussed these issues in Uganda and Malawi.

Published
12 April 2013
From
GNP+
Epidemiology
Less South Africans Dying of HIV/Aids, but More of Diabetes

Government's annual death report has confirmed the trend that less South Africans have been dying of HIV/AIDS-related diseases. However, more people are dying of non-communicable diseases such as diabetes. ...

Published
11 April 2013
From
AllAfrica.com
Finance and funding
Preparing for Generics: The push for affordable HIV treatment doesn’t end with patent expirations

The United States is on course for some much-needed economic relief from the crippling cost of HIV treatment, with the anticipated arrival of generic versions of guidelines- preferred antiretrovirals. However, much preparation is required to maximize price competition, maintain patient choice, and ensure that savings are used to the advantage of people living with HIV.

Published
11 April 2013
From
Treatment Action Group
HIV treatment
South Africa: HIV patients still waiting for easier-to-take drugs

Health Minister Aaron Motsoaledi announced in December that fixed dose combination treatment would be in the 2013 HIV drug tender and become available in clinics in April. It is now 10 April and still most clinics in Khayelitsha do not have these pills.

Published
10 April 2013
From
Ground Up
Pharmaceutical industry
South Africa rolls out new single dose AIDS drug

South Africa's health minister on Monday launched a new single dose anti-AIDs drug which will simplify the world's biggest HIV treatment regime to just one life-saving pill a day. The tablet contains tenofovir, entricitabine and efavirenz.

Published
10 April 2013
From
France 24
Reproductive health
One-in-four deaths in pregnancy due to HIV in worst-affected countries

One-in-four pregnancy-related deaths is due to HIV in countries with a high HIV prevalence, a meta-analysis of 23 studies shows.HIV-infected women have eight times the

Published
09 April 2013
By
Carole Leach-Lemens
Prevention of mother-to-child transmission
New, intensive trials planned on heels of Mississippi HIV 'cure'

A trial that involves drug cessation is fraught with ethical and medical difficulties, so the next steps going forward remain unclear. HIV specialists plan to meet over three days in May at a leadership retreat of the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) group to discuss how best to test if and when antiretroviral therapy can be halted for children born with HIV who achieve undetectable levels of the virus in their blood.

Published
08 April 2013
From
Nature Medicine
Adherence
Breaking the Silence on My Struggle With HIV Meds

Most days I forgot I even had HIV until it was time for me to take those pills. Then those days started to become more frequent. Then I started to resent those pills. For me those pills were a constant reminder that I AM LIVING WITH HIV.

Published
08 April 2013
From
The Body
← Prev1...34567...312Next →

Filter by country